Impact of COVID-19 on cutaneous squamous cell carcinoma severity in a tertiary referral center in Israel: Lessons for future pandemics

Deborah Korn; Sivan Sheffer-Levi; Maayan Eitan-Wexler; Stephanie Ben-Shushan; Mordechai Avner; Nir Hirshhorn; Meni Bracha; Alexander Mali; Roni Shereberk-Hasidim; Sharon Merims; Aron Popovtzer; Vered Molho-Pessach; Michal Lotem; Jonathan E Cohen

doi:10.1016/j.jdin.2025.09.003

Impact of COVID-19 on cutaneous squamous cell carcinoma severity in a tertiary referral center in Israel: Lessons for future pandemics

JAAD Int. 2025 Sep 29:24:1-3. doi: 10.1016/j.jdin.2025.09.003. eCollection 2026 Feb.

Authors

Deborah Korn¹, Sivan Sheffer-Levi², Maayan Eitan-Wexler^{1

3}, Stephanie Ben-Shushan⁴, Mordechai Avner¹, Nir Hirshhorn⁵, Meni Bracha⁶, Alexander Mali⁴, Roni Shereberk-Hasidim², Sharon Merims¹, Aron Popovtzer¹, Vered Molho-Pessach², Michal Lotem^{1

3}, Jonathan E Cohen^{1

3}

Affiliations

¹ Sharett Institute of Oncology, Hadassah Cancer Research Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
² Department of Dermatology, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
³ The Wohl Institute for Translational Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
⁴ Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
⁵ Department of Otolaryngology/Head & Neck Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
⁶ Department of General Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

No abstract available

Keywords: COVID-19 pandemic; cancer outcomes; elderly patients; health care access; health care disruption; immunosuppression; medical surveillance; squamous cell carcinoma.